Arcus Biosciences, Inc.
US ˙ NYSE ˙ US03969F1093

SecurityRCUS / Arcus Biosciences, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership1,329,935 shares
Latest Disclosed Value $ 28,726,596
Citadel Advisors Llc ownership in RCUS / Arcus Biosciences, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 1,329,935 shares of Arcus Biosciences, Inc. (US:RCUS) valued at $28,726,596 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 104,701 shares of Arcus Biosciences, Inc.. This represents a change in shares of 1,170.22% during the quarter. The current value of the position is $30,841,193 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (RCUS) in the form of stock options. The firm currently holds call options representing 80,500 of underlying shares valued at $1,738,800 USD and put options representing 10,000 of underlying shares valued at $216,000 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

RCUS / Arcus Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ARCUS BIOSCIENCES COM 03969F109 1,329,935 1,225,234 1,170.22 28,727 1,051.34 0.0041
2026-02-17 2025-12-31 13F ARCUS BIOSCIENCES COM 03969F109 104,701 -190,353 -64.51 2,495 -37.81 0.0004
2025-11-14 2025-09-30 13F ARCUS BIOSCIENCES COM 03969F109 295,054 -316,141 -51.73 4,013 -19.36 0.0006
2025-08-14 2025-06-30 13F ARCUS BIOSCIENCES COM 03969F109 611,195 234,097 62.08 4,975 68.07 0.0009
2025-05-15 2025-03-31 13F ARCUS BIOSCIENCES COM 03969F109 377,098 16,504 4.58 2,960 -44.87 0.0006
2025-02-14 2024-12-31 13F ARCUS BIOSCIENCES COM 03969F109 360,594 42,723 13.44 5,369 10.47 0.0009
2024-11-14 2024-09-30 13F ARCUS BIOSCIENCES COM 03969F109 317,871 -149,292 -31.96 4,860 -31.68 0.0009
2024-08-14 2024-06-30 13F ARCUS BIOSCIENCES COM 03969F109 467,163 112,242 31.62 7,115 6.18 0.0014
2024-05-15 2024-03-31 13F ARCUS BIOSCIENCES COM 03969F109 354,921 78,997 28.63 6,701 27.13 0.0013
2024-02-14 2023-12-31 13F ARCUS BIOSCIENCES COM 03969F109 275,924 -9,923 -3.47 5,270 2.73 0.0011
2023-11-14 2023-09-30 13F ARCUS BIOSCIENCES COM 03969F109 285,847 -449,782 -61.14 5,131 -65.66 0.0011
2023-08-14 2023-06-30 13F ARCUS BIOSCIENCES COM 03969F109 735,629 -1,030,379 -58.35 14,941 -53.62 0.0031
2023-05-15 2023-03-31 13F ARCUS BIOSCIENCES COM 03969F109 1,766,008 1,122,779 174.55 32,212 142.17 0.0071
2023-02-14 2022-12-31 13F ARCUS BIOSCIENCES COM 03969F109 643,229 616,739 2,328.20 13,302 1,819.34 0.0031
2022-11-14 2022-09-30 13F ARCUS BIOSCIENCES COM 03969F109 26,490 -25,393 -48.94 693 -47.30 0.0002
2022-08-15 2022-06-30 13F ARCUS BIOSCIENCES COM 03969F109 51,883 31,975 160.61 1,315 109.39 0.0003
2022-05-16 2022-03-31 13F ARCUS BIOSCIENCES COM 03969F109 19,908 -141,902 -87.70 628 -90.41 0.0001
2022-02-14 2021-12-31 13F ARCUS BIOSCIENCES COM 03969F109 161,810 133,722 476.08 6,548 568.85 0.0013
2021-11-15 2021-09-30 13F ARCUS BIOSCIENCES Cmn 03969F109 28,088 -14,061 -33.36 979 -15.38 0.0002
2021-08-16 2021-06-30 13F ARCUS BIOSCIENCES COM 03969F109 42,149 -11,003 -20.70 1,157 -22.51 0.0003
2021-05-21 2021-03-31 13F/A-1 ARCUS BIOSCIENCES COM 03969F109 53,152 -42,361 -44.35 1,493 -39.77 0.0004
2021-05-17 2021-03-31 13F ARCUS BIOSCIENCES COM 03969F109 53,152 -42,361 1,493 0.0004
2021-02-16 2020-12-31 13F ARCUS BIOSCIENCES COM 03969F109 95,513 -20,471 -17.65 2,479 24.70 0.0006
2020-11-16 2020-09-30 13F ARCUS BIOSCIENCES COM 03969F109 115,984 -254,042 -68.66 1,988 -78.29 0.0006
2020-08-14 2020-06-30 13F ARCUS BIOSCIENCES Cmn 03969F109 370,026 338,436 1,071.34 9,155 1,985.42 0.0033
2020-05-15 2020-03-31 13F ARCUS BIOSCIENCES Cmn 03969F109 31,590 -25,494 -44.66 439 -23.92 0.0002
2020-02-14 2019-12-31 13F ARCUS BIOSCIENCES Cmn 03969F109 57,084 2,042 3.71 577 15.17 0.0003
2019-11-14 2019-09-30 13F ARCUS BIOSCIENCES Cmn 03969F109 55,042 -14,495 -20.85 501 -9.40 0.0002
2019-08-14 2019-06-30 13F ARCUS BIOSCIENCES Cmn 03969F109 69,537 52,018 296.92 553 152.51 0.0003
2019-05-15 2019-03-31 13F ARCUS BIOSCIENCES Cmn 03969F109 17,519 17,519 219 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ARCUS BIOSCIENCES COM Call 80,500 -14.90 1,739 -22.89 n/a n/a n/a
2026-02-17 2025-12-31 13F ARCUS BIOSCIENCES COM Call 94,600 -8.60 2,254 60.20 n/a n/a n/a
2025-11-14 2025-09-30 13F ARCUS BIOSCIENCES COM Call 103,500 36.18 1,408 127.67 n/a n/a n/a
2025-08-14 2025-06-30 13F ARCUS BIOSCIENCES COM Call 76,000 128.92 619 137.69 n/a n/a n/a
2025-05-15 2025-03-31 13F ARCUS BIOSCIENCES COM Call 33,200 -15.52 261 -55.56 n/a n/a n/a
2025-02-14 2024-12-31 13F ARCUS BIOSCIENCES COM Call 39,300 150.32 585 143.75 n/a n/a n/a
2024-11-14 2024-09-30 13F ARCUS BIOSCIENCES COM Call 15,700 460.71 240 471.43 n/a n/a n/a
2024-08-14 2024-06-30 13F ARCUS BIOSCIENCES COM Call 2,800 -86.14 43 -88.98 n/a n/a n/a
2024-05-15 2024-03-31 13F ARCUS BIOSCIENCES COM Call 20,200 9.19 381 7.93 n/a n/a n/a
2024-02-14 2023-12-31 13F ARCUS BIOSCIENCES COM Call 18,500 -2.12 353 4.13 n/a n/a n/a
2023-11-14 2023-09-30 13F ARCUS BIOSCIENCES COM Call 18,900 -45.69 339 -51.98 n/a n/a n/a
2023-08-14 2023-06-30 13F ARCUS BIOSCIENCES COM Call 34,800 52.63 707 70.12 n/a n/a n/a
2023-05-15 2023-03-31 13F ARCUS BIOSCIENCES COM Call 22,800 39.02 416 22.42 n/a n/a n/a
2023-02-14 2022-12-31 13F ARCUS BIOSCIENCES COM Call 16,400 339 n/a n/a n/a
2022-11-14 2022-09-30 13F ARCUS BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F ARCUS BIOSCIENCES COM Call 58,500 613.41 1,482 472.20 n/a n/a n/a
2022-05-16 2022-03-31 13F ARCUS BIOSCIENCES COM Call 8,200 -33.33 259 -47.99 n/a n/a n/a
2022-02-14 2021-12-31 13F ARCUS BIOSCIENCES COM Call 12,300 498 n/a n/a n/a
2022-03-11 2021-09-30 13F/A ARCUS BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F ARCUS BIOSCIENCES COM Call 0 0 n/a n/a n/a
2021-08-16 2021-06-30 13F ARCUS BIOSCIENCES COM Call 32,800 212.38 901 205.42 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ARCUS BIOSCIENCES COM Call 10,500 295 n/a n/a n/a
2021-05-17 2021-03-31 13F ARCUS BIOSCIENCES COM Call 10,500 295 n/a n/a n/a
2021-02-16 2020-12-31 13F ARCUS BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F ARCUS BIOSCIENCES COM Call 85,000 1,457 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ARCUS BIOSCIENCES COM Put 10,000 -73.19 216 -75.68 n/a n/a n/a
2026-02-17 2025-12-31 13F ARCUS BIOSCIENCES COM Put 37,300 4.48 889 83.09 n/a n/a n/a
2025-11-14 2025-09-30 13F ARCUS BIOSCIENCES COM Put 35,700 -11.41 486 47.87 n/a n/a n/a
2025-08-14 2025-06-30 13F ARCUS BIOSCIENCES COM Put 40,300 13.20 328 17.56 n/a n/a n/a
2025-05-15 2025-03-31 13F ARCUS BIOSCIENCES COM Put 35,600 57.52 279 -16.96 n/a n/a n/a
2025-02-14 2024-12-31 13F ARCUS BIOSCIENCES COM Put 22,600 -11.02 337 -13.40 n/a n/a n/a
2024-11-14 2024-09-30 13F ARCUS BIOSCIENCES COM Put 25,400 -12.71 388 -12.42 n/a n/a n/a
2024-08-14 2024-06-30 13F ARCUS BIOSCIENCES COM Put 29,100 54.79 443 25.14 n/a n/a n/a
2024-05-15 2024-03-31 13F ARCUS BIOSCIENCES COM Put 18,800 -43.20 355 -43.99 n/a n/a n/a
2024-02-14 2023-12-31 13F ARCUS BIOSCIENCES COM Put 33,100 -7.02 632 -1.10 n/a n/a n/a
2023-11-14 2023-09-30 13F ARCUS BIOSCIENCES COM Put 35,600 -10.33 639 -20.72 n/a n/a n/a
2023-08-14 2023-06-30 13F ARCUS BIOSCIENCES COM Put 39,700 -20.76 806 -11.72 n/a n/a n/a
2023-05-15 2023-03-31 13F ARCUS BIOSCIENCES COM Put 50,100 -24.77 914 -33.70 n/a n/a n/a
2023-02-14 2022-12-31 13F ARCUS BIOSCIENCES COM Put 66,600 161.18 1,377 106.45 n/a n/a n/a
2022-11-14 2022-09-30 13F ARCUS BIOSCIENCES COM Put 25,500 -74.22 667 -73.38 n/a n/a n/a
2022-08-15 2022-06-30 13F ARCUS BIOSCIENCES COM Put 98,900 697.58 2,506 540.92 n/a n/a n/a
2022-05-16 2022-03-31 13F ARCUS BIOSCIENCES COM Put 12,400 -68.53 391 -75.49 n/a n/a n/a
2022-02-14 2021-12-31 13F ARCUS BIOSCIENCES COM Put 39,400 173.61 1,595 217.73 n/a n/a n/a
2021-11-15 2021-09-30 13F ARCUS BIOSCIENCES Cmn Put 14,400 -69.30 502 -61.02 n/a n/a n/a
2021-08-16 2021-06-30 13F ARCUS BIOSCIENCES COM Put 46,900 -47.89 1,288 -49.03 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ARCUS BIOSCIENCES COM Put 90,000 3.69 2,527 12.16 n/a n/a n/a
2021-05-17 2021-03-31 13F ARCUS BIOSCIENCES COM Put 90,000 2,527 n/a n/a n/a
2021-02-16 2020-12-31 13F ARCUS BIOSCIENCES COM Put 86,800 557.58 2,253 896.90 n/a n/a n/a
2020-11-16 2020-09-30 13F ARCUS BIOSCIENCES COM Put 13,200 226 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.